Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Junyi Wang"'
Autor:
Changhao Liu, Huaiwu Lu, Xiaoyan Feng, Qunxian Rao, qingsong chen, Yuan Wei, Junyi Wang, Tianran Shen, Meimei Guan
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8310-8319 (2021)
Cancer Medicine
Cancer Medicine
Background Hepatitis B virus (HBV) infection has been associated with an increased risk of a few malignancies. However, the prognostic impact of HBV infection remains unclear in cervical cancer. Objective To explore the association between HBV infect
Autor:
Junyi Wang, Ming Bai, Yi Ba, Bei Sun, Haiyang Zhang, Rui Liu, Guoguang Ying, Kegan Zhu, Dan Lin, Yuchong Yang, Tao Ning, Shaohua Ge, Ting Deng, Jingjing Duan
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 12, Pp 3430-3446 (2021)
Molecular Oncology, Vol 15, Iss 12, Pp 3430-3446 (2021)
Fatty acid oxidation (FAO) plays a vital role in drug resistance in cancer cells. Carnitine palmitoyltransferase 1A (CPT1A), a key enzyme of FAO, is widely recognized as an emerging therapeutic target. Here, we confirmed that CPT1A was heterogeneousl
Autor:
Hanquan Wu, Dengwen Dong, Jiwei Wang, Shiwen Yin, Yuanxiang Gong, Chao Yang, Yihan Bai, Junyi Wang, Yanhong Du
Publikováno v:
Technology in cancer researchtreatment. 21
Background: Long noncoding RNAs have been associated with various types of malignant tumors; however, the specific role of long noncoding RNAs in tumorigenesis still remains unclear in colorectal cancer. Here, we aim to elucidate the role of long non
Autor:
Dapeng Li, Mengran Tian, Yan Zhang, Yang Yu, Wenyuan Cheng, Yigong Li, Junyi Wang, Songfeng Wei, Xin Wang, Xiaoyong Yang, Jingzhu Zhao, Xinwei Yun, Wei Zhang, Jiayin Song, Huan Zhang, Xiangqian Zheng, Ming Gao
Publikováno v:
Frontiers in oncology. 12
BackgroundHypocalcemia is the most common complication that challenges surgeons performing total thyroidectomy. Conventional postoperative calcium and calcitriol supplement has been reportedly effective; however, a time lag has been reported before t
Autor:
Rong Deng, Yuxiang Dong, Yitong Pan, Lin Chen, Ping Liu, Yun Yu, Jianing Lu, Junyi Wang, Yuhan Zhang, Chen Chen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Breast cancer is one of the main malignant tumors that threaten the lives of women, which has received more and more clinical attention worldwide. There are increasing evidences showing that the immune micro-environment of breast cancer (B
Autor:
Bin Li, Junyi Wang, Jing Liao, Minghui Wu, Xiangshu Yuan, Hezhi Fang, Lijun Shen, Minghua Jiang
Publikováno v:
Cancer cell international. 22(1)
KRAS-driven metabolic reprogramming is one of the key features of pancreatic ductal adenocarcinoma (PDAC) cells; however, the metabolic roles of other oncogenic genes, such as YY1, in PDAC development are still unclear. In this study, we observed tha
Autor:
Qi Chen, Yelin Mao, Na Zhao, Lichan Yuan, Erik A.C. Wiemer, Liu Yuying, Li Meng, Shuyu Guo, Jingjing Ben, Junqing Ma, Junyi Wang
Publikováno v:
Theranostics, 11(15), 7247-7261. Ivyspring International Publisher
Theranostics
Theranostics
Rationale: Bone homeostasis is maintained by a balanced interplay of osteoblasts and osteoclasts. Osteoclasts are derived from monocyte/macrophage lineage. Major vault protein (MVP) is known to promote apoptosis and prevent metabolic diseases in macr
Publikováno v:
Frontiers in Oncology. 12
BackgroundThe incidence of papillary thyroid carcinoma (PTC) in children and adolescents has increased, but the data on long-term outcomes are limited. There are few literatures on the clinicopathological characteristics and prognosis of PTC in child
Autor:
Jianjun Hu, Jiangyi He, Yunlong Wang, Yang Zhao, Kejing Fang, Yan Dong, Yanrong Chen, Yue Zhang, Chi Zhang, Hongwei Wang, Jun Tan, Junyi Wang, Ruiyang Zi, Chengxiang Liu, Houjie Liang, Yanli Guo, Juanjuan Ou
Publikováno v:
Journal for immunotherapy of cancer. 10(3)
BackgroundThe poor immunogenicity of solid tumors limits the efficacy ofanti-programmed cell death protein 1 (anti-PD1)-based immune checkpoint blockade (ICB); thus, less than 30% of patients with cancer exhibit a response. Currently, there is still
Autor:
Junyi Wang, Lei Zhang, Li Luo, Ping He, Anying Xiong, Manling Jiang, Yao Liu, Shengbin Liu, Qin Ran, Dehong Wu, Ying Xiong, Xiang He, Guoping Li
Publikováno v:
Cell Death Discovery
Cell Death Discovery, Vol 8, Iss 1, Pp 1-13 (2022)
Cell Death Discovery, Vol 8, Iss 1, Pp 1-13 (2022)
Fibrotic hypersensitivity pneumonitis (FHP) remains one of fatal interstitial pulmonary disease. Comprehensively dissecting the cellular heterogeneity of FHP paves the way for developing general gene therapeutic solutions for FHP. Here, utilizing an